Search

Your search keyword '"N. Téllez"' showing total 155 results

Search Constraints

Start Over You searched for: Author "N. Téllez" Remove constraint Author: "N. Téllez"
155 results on '"N. Téllez"'

Search Results

3. Synthesis of superficially modified Ce1−x(Zr + Y)xO2−δ solid solutions and thermogravimetric analysis of their performance in the catalytic soot combustion

5. OCT Variability Prevents Their Use as Robust Biomarkers in Multiple Sclerosis

6. Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease

7. 13th Post-ECTRIMS Meeting: review of the new developments presented at the 2020 ECTRIMS Congress (II)

8. 12th Post-ECTRIMS Meeting: review of the novelties from the 2019 ECTRIMS Congress (II)

9. Citotoxicidad de metabolitos secundarios de algunas plantas colombianas

10. Clinical manifestations of the anti-IgLON5 disease

11. Immune Tolerance in Multiple Sclerosis and Neuromyelitis Optica with Peptide-Loaded Tolerogenic Dendritic Cells in a Phase 1b Trial

12. XIII Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2020 (I)

13. XII Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2019 (I)

14. XII Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2019 (II)

15. Netrin‐1 and multiple sclerosis: a new biomarker for neuroinflammation?

16. Revisión de las novedades presentadas en el congreso ECTRIMS 2018: XI Reunión Post-ECTRIMS (I)

19. Primary progressive multiple sclerosis diagnostic criteria: a reappraisal

20. Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple sclerosis

21. Relationship between MRI lesion activity and response to IFN-β in relapsing–remitting multiple sclerosis patients

22. The basal ganglia: a substrate for fatigue in multiple sclerosis

23. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?

24. Nueva fuente de quinoles, la superficie foliar de Pentacalia ledifolia y Pentacalia corymbosa y sus propiedades antifúngicas

25. Baseline MRI predicts future attacks and disability in clinically isolated syndromes

26. Defining the response to interferon‐β in relapsing‐remitting multiple sclerosis patients

27. Interferon beta in relapsing–remitting multiple sclerosis

28. Differential expression of AP-1 transcription factor genes c-fos and c-jun in the helminth parasites Taenia crassiceps and Taenia solium

29. Improvement of fatigue in multiple sclerosis by physical exercise is associated to modulation of systemic interferon response

30. Neuromyelitis optica diagnosis in clinically isolated syndromes suggestive of multiple sclerosis

31. Efeitos citotóxicos in vitro de extratos e frações de Bursera tomentosa (Jacq.) Triana & Planch., Burseraceae, frente a linhagens celulares tumorais humanos

32. Clinical features of CIS of the brainstem/cerebellum of the kind seen in MS

33. Very early scans for demonstrating dissemination in time in multiple sclerosis

34. Pregnancy in multiple sclerosis patients treated with immunomodulators prior to or during part of the pregnancy: a descriptive study in the Spanish population

35. Polyregional and hemispheric syndromes: a study of these uncommon first attacks in a CIS cohort

36. Long-term emotional state of multiple sclerosis patients treated with interferon beta

37. Princípio ativo citotóxico de Espeletia killipii Cuatr. sobre células tumorais e sua toxicidade frente a células normais humanas

38. Efectos citotoxicos in vitro de extractos y fracciones de Espeletia killipii Cuatr. frente a lineas celulares tumorales humanos

39. Fatigue in multiple sclerosis persists over time: a longitudinal study

40. Long-term clinical outcome of primary progressive MS:Predictive value of clinical and MRI data

41. Factors related with treatment adherence to interferon beta and glatiramer acetate therapy in multiple sclerosis

42. Multiple sclerosis severity score: Using disability and disease duration to rate disease severity

43. 40(th) EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004

44. Evidence that steroid 5alpha-reductase isozyme genes are differentially methylated in human lymphocytes

45. [Posterior spinal artery infarction and nonbacterial thrombotic endocarditis]

46. Efecto a largo plazo de los anticuerpos neutralizantes de interferón beta-1 b en pacientes con esclerosis múltiple

49. Interferon Beta-1b for the Treatment of Primary Progressive Multiple Sclerosis

50. Revisión de las novedades presentadas en el XXVI Congreso del Comité Europeo para el Tratamiento e Investigación en Esclerosis Múltiple (ECTRIMS) (I)

Catalog

Books, media, physical & digital resources